Mahmoud Elhussein Elbadry, Adachi Nobuo, Mawas Amany Sayed, Gaarour Osama Samir, Ochi Mitsuo
1 Department of Surgery, Faculty of Veterinary Medicine, South Valley University, Qena, Egypt.
2 Department of Orthopaedic Surgery, Integrated Health Sciences, Institute of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan.
J Orthop Surg (Hong Kong). 2019 May-Aug;27(2):2309499019839850. doi: 10.1177/2309499019839850.
Choosing a therapeutic cell source for osteochondral repair remains a challenge. The present study investigated coculturing mesenchymal stem cells (MSCs) from different sources to provide an improved therapeutic cell option for osteochondral repair.
Dutch and Japanese white rabbits were used in this study, the first for isolating MSCs and the second for creating an osteochondral model in the medial femoral condyle. The 26 rabbit knees were divided randomly into four groups: control ( n = 6), bone marrow-derived MSCs (BMSCs) ( n = 7), synovial tissue MSCs (SMSCs) ( n = 7), and cocultured MSCs ( n = 6). Tissue repair was assessed using the Fortier scale, and colony-forming assay was performed.
At different cell densities, cocultured and SMSCs formed larger colonies than BMSCs, indicating their high proliferative potential. After 2 months, complete filling of the defect with smooth surface regularity was detected in the cocultured MSC group, although there was no significant difference among the therapeutic groups macroscopically. Also, tissue repair was histologically better in the cocultured MSC group than in the control and SMSC groups, due to repair of the subchondral bone and coverage with hyaline cartilage. Additionally, toluidine blue and collagen-II staining intensity in the repaired tissue was better in the cocultured MSC group than in the remaining groups.
Our results suggest that cocultured MSCs are a suitable option for the regeneration capability of osteochondral defects due to their enhanced osteochondrogenic potential.
选择用于骨软骨修复的治疗性细胞来源仍然是一项挑战。本研究调查了不同来源间充质干细胞(MSCs)的共培养,以为骨软骨修复提供更好的治疗性细胞选择。
本研究使用了荷兰白兔和日本白兔,前者用于分离MSCs,后者用于在股骨内侧髁创建骨软骨模型。26个兔膝关节被随机分为四组:对照组(n = 6)、骨髓来源的MSCs(BMSCs)组(n = 7)、滑膜组织MSCs(SMSCs)组(n = 7)和共培养MSCs组(n = 6)。使用Fortier评分评估组织修复情况,并进行集落形成试验。
在不同细胞密度下,共培养的MSCs和SMSCs形成的集落比BMSCs更大,表明它们具有较高的增殖潜力。2个月后,共培养MSCs组缺损完全填充,表面规则光滑,尽管各治疗组在宏观上无显著差异。此外,共培养MSCs组的组织修复在组织学上优于对照组和SMSCs组,原因是软骨下骨得到修复并被透明软骨覆盖。此外,共培养MSCs组修复组织中的甲苯胺蓝和Ⅱ型胶原染色强度优于其他组。
我们的结果表明,共培养的MSCs由于其增强的骨软骨生成潜力,是骨软骨缺损再生能力的合适选择。